N-Trifluoroacetamido-4′-p-nitrobenzoyl Daunorubicin (CAS 52583-24-1)

N-Trifluoroacetamido-4′-p-nitrobenzoyl Daunorubicin is a chemical compound utilized extensively in biochemical and pharmacological research, particularly in the study of drug delivery systems. This compound is a derivative of daunorubicin, a well-known anthracycline antibiotic with potent anticancer properties. In research, the N-trifluoroacetamido and p-nitrobenzoyl groups are strategically incorporated into daunorubicin to enhance its stability, solubility, and specificity for cancer cells. The trifluoroacetamido moiety aids in improving the pharmacokinetic profile of the compound, enhancing its cellular uptake and retention. Additionally, the p-nitrobenzoyl group serves as a photoactivatable moiety, allowing for light-mediated release of the active drug at the targeted site, enabling spatial and temporal control over drug delivery. Researchers employ this chemical conjugate in the development of novel drug delivery systems, including prodrugs, nanoparticles, and liposomes, for site-specific delivery of anticancer agents to tumor tissues while minimizing off-target effects and systemic toxicity. Furthermore, studies investigating the cellular uptake mechanisms, intracellular trafficking, and efficacy of N-Trifluoroacetamido-4′-p-nitrobenzoyl Daunorubicin contribute to advancements in cancer research and personalized medicine approaches.